Austin Health

Title
Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum.
Publication Date
2022-04-05
Author(s)
Doré, Vincent
Doecke, James D
Saad, Ziad S
Triana-Baltzer, Gallen
Slemmon, Randy
Krishnadas, Natasha
Bourgeat, Pierrick
Huang, Kun
Burnham, Samantha
Fowler, Christopher
Rainey-Smith, Stephanie R
Bush, Ashley I
Ward, Larry
Robertson, Jo
Martins, Ralph N
Masters, Colin L
Villemagne, Victor L
Fripp, Jurgen
Kolb, Hartmuth C
Rowe, Christopher C
Subject
Alzheimer's disease
Aβ imaging
amyloid imaging
amyloid plaque
blood biomarkers
blood diagnostic for Alzheimer's disease
paired helical filaments
phosphorylated tau
plasma P‐tau217
positron emission tomography
tau imaging
Type of document
Journal Article
OrcId
https://orcid.org/0000-0002-8051-0558
https://orcid.org/0000-0002-5374-2839
https://orcid.org/0000-0003-1397-0359
https://orcid.org/0000-0001-8259-9069
https://orcid.org/0000-0003-3072-7940
https://orcid.org/0000-0002-5832-9875
https://orcid.org/0000-0003-3910-2453
DOI
10.1002/dad2.12307
Abstract
We evaluated a new Simoa plasma assay for phosphorylated tau (P-tau) at aa217 enhanced by additional p-tau sites (p217+tau). Plasma p217+tau levels were compared to 18F-NAV4694 amyloid beta (Aβ) positron emission tomography (PET) and 18F-MK6240 tau PET in 174 cognitively impaired (CI) and 223 cognitively unimpaired (CU) participants. Compared to Aβ- CU, the plasma levels of p217+tau increased 2-fold in Aβ+ CU and 3.5-fold in Aβ+ CI. In Aβ- the p217+tau levels did not differ significantly between CU and CI. P217+tau correlated with Aβ centiloids P = .67 (CI, P = .64; CU, P = .45) and tau SUVRMT P = .63 (CI, P = .69; CU, P = .34). Area under curve (AUC) for Alzheimer's disease (AD) dementia versus Aβ- CU was 0.94, for AD dementia versus other dementia was 0.93, for Aβ+ versus Aβ- PET was 0.89, and for tau+ versus tau- PET was 0.89. Plasma p217+tau levels elevate early in the AD continuum and correlate well with Aβ and tau PET.
Link
Citation
Alzheimer's & Dementia (Amsterdam, Netherlands) 2022; 14(1): e12307
Jornal Title
Alzheimer's & Dementia (Amsterdam, Netherlands)
ISSN
2352-8729

Files:

NameSizeformatDescriptionLink